Oxford MediStress Limited

Oxford MediStress is a medical technology spin-out from the University of Oxford that specializes in stress measurement and diagnosis. The company has developed and commercialized a patented in vitro blood test known as the Leukocyte CopingCapacity (LCC) system. This proprietary technology uses a finger-prick drop of blood to provide an objective, rapid, and quantitative measurement of physiological and psychological stress levels in approximately 10 minutes. By monitoring the reactivity of white blood cells (leukocytes) as bio-indicators, the system offers a real-time point-of-care solution designed to be more sensitive than traditional cortisol-based stress measurements.

The technology is applied across various sectors, including occupational health, professional sports, clinical trials, and veterinary medicine, to help manage and optimize well-being. For example, it is used to monitor stress in corporate executives, athletes, and animals, as well as in high-stress industries like offshore oil and gas through projects such as WorkWeLCC. By providing actionable data, the company aims to help organizations effectively manage employee health, improve training loads for athletes, and enhance animal welfare. Oxford MediStress continues to expand the reach of its LCC platform through research, clinical validation, and government-supported initiatives focused on improving access to occupational health services.